SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-18-000061
Filing Date
2018-11-05
Accepted
2018-11-05 16:11:36
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks2018093010-q.htm 10-Q 771656
2 EXHIBIT 31.1 flks20180930ex-311.htm EX-31.1 10247
3 EXHIBIT 31.2 flks20180930ex-312.htm EX-31.2 10296
4 EXHIBIT 32.1 flks20180930ex-321.htm EX-32.1 9405
  Complete submission text file 0001615219-18-000061.txt   4442859

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flks-20180930.xml EX-101.INS 894863
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20180930.xsd EX-101.SCH 33181
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20180930_cal.xml EX-101.CAL 55669
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20180930_def.xml EX-101.DEF 150979
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20180930_lab.xml EX-101.LAB 479004
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20180930_pre.xml EX-101.PRE 278457
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 181160030
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences